시장보고서
상품코드
1552509

세계의 DNA 및 유전자 클로닝 서비스 시장 - 규모, 점유율, 동향, 산업 분석 보고서 : 제공 서비스 유형별, 유전자 유형별, 최종 사용자 산업별, 지역별 시장 예측(2024-2032년)

DNA and Gene Cloning Services Market Size, Share, Trends, Industry Analysis Report: By Type of Service Offered, Type of Gene, End-User Industry, and By Region - Market Forecast, 2024-2032

발행일: | 리서치사: Polaris Market Research | 페이지 정보: 영문 119 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최근 조사에 따르면 세계 DNA 및 유전자 클로닝 서비스 시장 규모는 2032년까지 82억 162만 달러에 이를 전망입니다. 이 설문조사 보고서는 현재 시장 역학을 자세히 파악하고 향후 시장 성장에 대한 분석을 제공합니다.

DNA 및 유전자 클로닝 서비스 세계 시장은 유전자 연구와 생명공학의 진보에 힘입어 대폭적인 성장을 이루고 있습니다. 이 시장은 유전자 합성, 서브클로닝, 돌연변이유발, 벡터 구축 등 다양한 서비스를 제공하고 있으며, 학술기관, 제약회사, 바이오테크놀러지 기업에 서비스를 제공합니다. 주요 촉진요인으로는 맞춤형 의료에 대한 수요 증가와 유전성 질환의 발생률 증가 등이 있으며, 모두 고급 연구 및 치료 솔루션이 필요합니다. 게다가 중요한 동향으로서 정확한 유전자 편집을 위한 CRISPR 기술의 채용과 합성 생물학 응용의 확대가 있으며, 이들 모두는 기술 혁신을 촉진하고 이용 가능한 클로닝 서비스의 범위를 확대하고 있습니다.

DNA 및 유전자 클로닝 서비스 시장 경쟁 구도은 치열한 경쟁과 지속적인 혁신을 특징으로 합니다. Thermo Fisher Scientific과 GenScript는 광범위한 서비스 포트폴리오와 세계의 존재로 시장을 선도하고 있습니다.

DNA 및 유전자 클로닝 서비스 시장 보고서 하이라이트 :

제공 서비스 유형을 기반으로, 유전자 합성 부문은 다양한 유전자 연구 및 생명 공학 애플리케이션을 홍보하는 데 중요한 역할을하기 위해 2023년 시장을 독점했습니다.

유전자 유형별로, 루틴의 유전자 연구, 진단 및 시장 개척에 널리 응용되고 있기 때문에 표준 유전자 부문이 2023년 시장을 독점했습니다.

제약·바이오테크놀러지 기업 부문이 2023년 최대 시장 점유율을 차지했습니다. 이러한 기업은 창약, 유전자 치료 개발, 바이오 의약품 생산을 위해 복제 서비스에 크게 의존하고 있습니다. 정확한 유전자 변형의 필요성과 신규 치료 솔루션의 개발이 이 부문에서 DNA 및 유전자 클로닝 서비스 수요를 촉진하고 있습니다.

북미는 시장을 독점하고 아시아태평양이 가장 높은 성장률을 보일 것으로 예상됩니다.

목차

제1장 서론

제2장 주요 요약

제3장 조사 방법

제4장 세계의 DNA 및 유전자 클로닝 서비스 시장 인사이트

  • 시장 현황
  • DNA 및 유전자 클로닝 서비스 시장 역학
    • 성장 촉진요인과 기회
    • 억제요인과 과제
  • PESTEL 분석
  • DNA 및 유전자 클로닝 서비스 시장 동향
  • 밸류체인 분석
  • COVID-19의 영향 분석

제5장 세계의 DNA 및 유전자 클로닝 서비스 시장 : 제공 서비스 유형별

  • 주요 조사 결과
  • 소개
  • 유전자 합성
  • 커스텀 클론
  • 서브 클로닝
  • 기타

제6장 세계의 DNA 및 유전자 클로닝 서비스 시장 : 유전자 유형별

  • 주요 조사 결과
  • 소개
  • 표준 유전자
  • 복합 유전자
  • 기타

제7장 세계의 DNA 및 유전자 클로닝 서비스 시장 : 최종 사용자 산업별

  • 주요 조사 결과
  • 소개
  • 학술과 연구·개발
  • 제약·바이오테크놀러지 기업
  • 기타

제8장 세계의 DNA 및 유전자 클로닝 서비스 시장 :지역별

  • 주요 조사 결과
  • 소개
    • DNA 및 유전자 클로닝 서비스 시장 평가:지역별, 2019-2032년
  • 북미
    • 북미 : 제공 서비스 유형별, 2019-2032년
    • 북미 : 유전자 유형별, 2019-2032년
    • 북미 : 최종사용자 산업별, 2019-2032년
    • 미국
    • 캐나다
  • 유럽
    • 유럽 : 제공 서비스 유형별, 2019-2032년
    • 유럽 : 유전자 유형별, 2019-2032년
    • 유럽 : 최종사용자 산업별, 2019-2032년
    • 영국
    • 프랑스
    • 독일
    • 이탈리아
    • 스페인
    • 네덜란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 아시아태평양: 제공 서비스 유형별, 2019-2032년
    • 아시아태평양: 유전자 유형별, 2019-2032년
    • 아시아태평양: 최종 사용자 산업별, 2019-2032년
    • 중국
    • 인도
    • 말레이시아
    • 일본
    • 인도네시아
    • 한국
    • 호주
    • 기타 아시아태평양
  • 중동 및 아프리카
    • 중동 및 아프리카: 제공 서비스 유형별, 2019-2032년
    • 중동 및 아프리카: 유전자 유형별, 2019-2032년
    • 중동 및 아프리카 : 최종사용자 산업별, 2019-2032년
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 남아프리카
    • 기타 중동 및 아프리카
  • 라틴아메리카
    • 라틴아메리카: 제공 서비스 유형별, 2019-2032년
    • 라틴아메리카 : 유전자 유형별, 2019-2032년
    • 라틴아메리카 : 최종사용자 산업별, 2019-2032년
    • 멕시코
    • 브라질
    • 아르헨티나
    • 기타 라틴아메리카

제9장 경쟁 구도

  • 확대와 인수 분석
    • 확대
    • 인수
  • 제휴/협업/합의/공개

제10장 기업 프로파일

  • Thermo Fisher Scientific
  • GenScript
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Merck KGaA
  • Takara Bio
  • New England Biolabs
  • Lonza Group
  • Integrated DNA Technologies
  • Origene Technologies
  • Creative Biogene
  • Genewiz
  • Addgene
  • Eurofins Scientific
  • Twist Bioscience
JHS 24.10.10

The global DNA and gene cloning services market size is expected to reach USD 8,201.62 million by 2032, according to a new study by Polaris Market Research. The report "Global DNA and Gene Cloning Services Market Size, Share, Trends, Industry Analysis Report: By Type of Service Offered (Gene Synthesis, Custom Cloning, Sub-cloning, and Others), By Type of Gene, End-User Industry, and By Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2024-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The global market for DNA and gene cloning services is witnessing substantial growth, fueled by advances in genetic research and biotechnology. The market offers a variety of services such as gene synthesis, subcloning, mutagenesis, and vector construction, serving academic institutions, pharmaceutical companies, and biotech firms. Key drivers include the rising demand for personalized medicine and the increasing incidence of genetic disorders, both of which require sophisticated research and treatment solutions. Additionally, significant trends include the adoption of CRISPR technology for accurate gene editing and the expansion of synthetic biology applications, both of which are driving innovation and enhancing the range of available cloning services.

The competitive landscape of the DNA and gene cloning services market is characterized by intense competition and continuous innovation. Thermo Fisher Scientific and GenScript lead the market with extensive service portfolios and strong global presence.

DNA and Gene Cloning Services Market Report Highlights:

Based on type of service offered, the gene synthesis segment dominated the market in 2023 due to its critical role in facilitating various genetic research and biotechnological applications.

By type of gene, the standard genes segment dominated the market in 2023 due to their widespread application in routine genetic research, diagnostics, and therapeutic developments.

The pharmaceutical and biotechnology companies' segment held the largest market share in 2023. These companies rely heavily on cloning services for drug discovery, gene therapy development, and biopharmaceutical production. The need for precise genetic modifications and the development of novel therapeutic solutions propel the demand for DNA and gene cloning services in this segment.

North America dominates the market, whereas Asia-Pacific is expected to witness the highest growth rate.

Polaris Market Research has segmented the DNA And Gene Cloning Services market report

DNA and Gene Cloning Services, Type of Service Outlook (Revenue - USD million, 2019-2032)

  • Gene Synthesis
  • Custom Cloning
  • Sub-cloning
  • Others

DNA and Gene Cloning Services, Type of Gene Outlook (Revenue - USD million, 2019-2032)

  • Standard Gene
  • Complex Gene
  • Others

DNA and Gene Cloning Services, End-User Industry Outlook (Revenue - USD million, 2019-2032)

  • Academic and R&D
  • Pharmaceutical and Biotechnology Companies
  • Others

DNA and Gene Cloning Services, Regional Outlook (Revenue - USD million, 2019-2032)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia-Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global DNA and Gene Cloning Services Market Insights

  • 4.1. DNA and Gene Cloning Services Market - Market Snapshot
  • 4.2. DNA and Gene Cloning Services Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Integration of CRISPR Technology
      • 4.2.1.2. Expansion of Synthetic Biology End-User Industrys
      • 4.2.1.3. Increasing Demand for Personalized Medicine
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Technical Complexity is Hindering the Market Growth
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. DNA and Gene Cloning Services Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global DNA and Gene Cloning Services Market, by Type of Service Offered

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
  • 5.3. Gene Synthesis
    • 5.3.1. Global DNA and Gene Cloning Services Market, by Gene Synthesis, by Region, 2019-2032 (USD million)
  • 5.4. Custom Cloning
    • 5.4.1. Global DNA and Gene Cloning Services Market, by Custom Cloning, by Region, 2019-2032 (USD million)
  • 5.5. Sub-cloning
    • 5.5.1. Global DNA and Gene Cloning Services Market, by Sub-cloning, by Region, 2019-2032 (USD million)
  • 5.6. Others
    • 5.6.1. Global DNA and Gene Cloning Services Market, by Others, by Region, 2019-2032 (USD million)

6. Global DNA and Gene Cloning Services Market, by Gene Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
  • 6.3. Standard Gene
    • 6.3.1. Global DNA and Gene Cloning Services Market, by Standard Gene, by Region, 2019-2032 (USD million)
  • 6.4. Complex Gene
    • 6.4.1. Global DNA and Gene Cloning Services Market, by Complex Gene, by Region, 2019-2032 (USD million)
  • 6.5. Others
    • 6.5.1. Global DNA and Gene Cloning Services Market, by Others, by Region, 2019-2032 (USD million)

7. Global DNA and Gene Cloning Services Market, by End-User Industry

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
  • 7.3. Academic and R&D
    • 7.3.1. Global DNA and Gene Cloning Services Market, by Academic and R&D, by Region, 2019-2032 (USD million)
  • 7.4. Pharmaceutical and Biotechnology Companies
    • 7.4.1. Global DNA and Gene Cloning Services Market, by Pharmaceutical and Biotechnology Companies, by Region, 2019-2032 (USD million)
  • 7.5. Others
    • 7.5.1. Global DNA and Gene Cloning Services Market, by Others, by Region, 2019-2032 (USD million)

8. Global DNA and Gene Cloning Services Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. DNA and Gene Cloning Services Market Assessment, By Geography, 2019-2032 (USD million)
  • 8.3. DNA and Gene Cloning Services Market - North America
    • 8.3.1. North America: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
    • 8.3.2. North America: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
    • 8.3.3. North America: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.3.4. DNA and Gene Cloning Services Market - U.S.
      • 8.3.4.1. U.S.: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.3.4.2. U.S.: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.3.4.3. U.S.: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.3.5. DNA and Gene Cloning Services Market - Canada
      • 8.3.5.1. Canada: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.3.5.2. Canada: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.3.5.3. Canada: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
  • 8.4. DNA and Gene Cloning Services Market - Europe
    • 8.4.1. Europe: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
    • 8.4.2. Europe: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
    • 8.4.3. Europe: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.4.4. DNA and Gene Cloning Services Market - UK
      • 8.4.4.1. UK: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.4.4.2. UK: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.4.4.3. UK: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.4.5. DNA and Gene Cloning Services Market - France
      • 8.4.5.1. France: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.4.5.2. France: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.4.5.3. France: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.4.6. DNA and Gene Cloning Services Market - Germany
      • 8.4.6.1. Germany: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.4.6.2. Germany: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.4.6.3. Germany: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.4.7. DNA and Gene Cloning Services Market - Italy
      • 8.4.7.1. Italy: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.4.7.2. Italy: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.4.7.3. Italy: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.4.8. DNA and Gene Cloning Services Market - Spain
      • 8.4.8.1. Spain: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.4.8.2. Spain: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.4.8.3. Spain: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.4.9. DNA and Gene Cloning Services Market - Netherlands
      • 8.4.9.1. Netherlands: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.4.9.2. Netherlands: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.4.9.3. Netherlands: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.4.10. DNA and Gene Cloning Services Market - Russia
      • 8.4.10.1. Russia: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.4.10.2. Russia: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.4.10.3. Russia: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.4.11. DNA and Gene Cloning Services Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.4.11.2. Rest of Europe: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.4.11.3. Rest of Europe: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
  • 8.5. DNA and Gene Cloning Services Market - Asia Pacific
    • 8.5.1. Asia Pacific: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
    • 8.5.2. Asia Pacific: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
    • 8.5.3. Asia Pacific: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.5.4. DNA and Gene Cloning Services Market - China
      • 8.5.4.1. China: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.5.4.2. China: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.5.4.3. China: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.5.5. DNA and Gene Cloning Services Market - India
      • 8.5.5.1. India: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.5.5.2. India: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.5.5.3. India: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.5.6. DNA and Gene Cloning Services Market - Malaysia
      • 8.5.6.1. Malaysia: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.5.6.2. Malaysia: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.5.6.3. Malaysia: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.5.7. DNA and Gene Cloning Services Market - Japan
      • 8.5.7.1. Japan: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.5.7.2. Japan: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.5.7.3. Japan: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.5.8. DNA and Gene Cloning Services Market - Indonesia
      • 8.5.8.1. Indonesia: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.5.8.2. Indonesia: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.5.8.3. Indonesia: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.5.9. DNA and Gene Cloning Services Market - South Korea
      • 8.5.9.1. South Korea: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.5.9.2. South Korea: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.5.9.3. South Korea: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.5.10. DNA and Gene Cloning Services Market - Australia
      • 8.5.10.1. Australia: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.5.10.2. Australia: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.5.10.3. Australia: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.5.11. DNA and Gene Cloning Services Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.5.11.2. Rest of Asia Pacific: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.5.11.3. Rest of Asia Pacific: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
  • 8.6. DNA and Gene Cloning Services Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
    • 8.6.2. Middle East & Africa: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
    • 8.6.3. Middle East & Africa: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.6.4. DNA and Gene Cloning Services Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.6.4.2. Saudi Arabia: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.6.4.3. Saudi Arabia: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.6.5. DNA and Gene Cloning Services Market - UAE
      • 8.6.5.1. UAE: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.6.5.2. UAE: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.6.5.3. UAE: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.6.6. DNA and Gene Cloning Services Market - Israel
      • 8.6.6.1. Israel: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.6.6.2. Israel: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.6.6.3. Israel: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.6.7. DNA and Gene Cloning Services Market - South Africa
      • 8.6.7.1. South Africa: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.6.7.2. South Africa: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.6.7.3. South Africa: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.6.8. DNA and Gene Cloning Services Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.6.8.2. Rest of Middle East & Africa: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.6.8.3. Rest of Middle East & Africa: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
  • 8.7. DNA and Gene Cloning Services Market - Latin America
    • 8.7.1. Latin America: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
    • 8.7.2. Latin America: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
    • 8.7.3. Latin America: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.7.4. DNA and Gene Cloning Services Market - Mexico
      • 8.7.4.1. Mexico: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.7.4.2. Mexico: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.7.4.3. Mexico: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.7.5. DNA and Gene Cloning Services Market - Brazil
      • 8.7.5.1. Brazil: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.7.5.2. Brazil: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.7.5.3. Brazil: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.7.6. DNA and Gene Cloning Services Market - Argentina
      • 8.7.6.1. Argentina: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.7.6.2. Argentina: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.7.6.3. Argentina: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)
    • 8.7.7. DNA and Gene Cloning Services Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: DNA and Gene Cloning Services Market, by Type of Service Offered, 2019-2032 (USD million)
      • 8.7.7.2. Rest of Latin America: DNA and Gene Cloning Services Market, by Gene Type, 2019-2032 (USD million)
      • 8.7.7.3. Rest of Latin America: DNA and Gene Cloning Services Market, by End-User Industry, 2019-2032 (USD million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Thermo Fisher Scientific
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. GenScript
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Agilent Technologies
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Bio-Rad Laboratories
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Merck KGaA
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Takara Bio
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. New England Biolabs
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Lonza Group
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Integrated DNA Technologies
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Origene Technologies
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Creative Biogene
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Genewiz
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Addgene
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Eurofins Scientific
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Twist Bioscience
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제